Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Preferred Shares: 2009-2010

Historic Preferred Shares for Ironwood Pharmaceuticals (IRWD) over the last 1 years, with Sep 2010 value amounting to $14,580.8 billion.

  • Ironwood Pharmaceuticals' Preferred Shares was N/A to $14,580.8 billion in Q3 2010 from the same period last year, while for Sep 2010 it was $14,580.8 billion, marking a year-over-year change of. This contributed to the annual value of $13.7 million for FY2009, which is N/A change from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Preferred Shares stood at $14,580.8 billion for Q3 2010, which was down 2.07% from $14,888.8 billion recorded in Q2 2010.
  • In the past 5 years, Ironwood Pharmaceuticals' Preferred Shares registered a high of $14,888.8 billion during Q2 2010, and its lowest value of $13.7 million during Q4 2009.
  • Its 2-year average for Preferred Shares is $11,425.9 billion, with a median of $14,580.8 billion in 2010.
  • Data for Ironwood Pharmaceuticals' Preferred Shares shows a peak YoY climbed of 13.48% (in 2010) over the last 5 years.
  • Ironwood Pharmaceuticals' Preferred Shares (Quarterly) stood at $13.7 million in 2009, then climbed by 13.48% to $14,580.8 billion in 2010.
  • Its Preferred Shares stands at $14,580.8 billion for Q3 2010, versus $14,888.8 billion for Q2 2010 and $14,703.1 billion for Q1 2010.